Copyright
©The Author(s) 2004.
World J Gastroenterol. Mar 15, 2004; 10(6): 910-912
Published online Mar 15, 2004. doi: 10.3748/wjg.v10.i6.910
Published online Mar 15, 2004. doi: 10.3748/wjg.v10.i6.910
Table 1 Blocking of maternal transmission in HBsAg and HBeAg double-positive mothers[19]
| n | HBsAg(+) | HBV-DNA(+) | Blockingrate | |||
| T0 | T6 | T12 | ||||
| Lamivudine treatment | 12 | 3 | 0 | 0 | 0 | 100.00 |
| Vaccine 30-30-10 μg | 81 | 21 | 21 | 21 | 74.07 | |
| Vaccine 30-20-10 μg | 37 | 13 | 13 | 13 | 64.87 | |
| Natural transmission | 10 | 10 | 10 | 10 | 0.00 | |
- Citation: Su GG, Pan KH, Zhao NF, Fang SH, Yang DH, Zhou Y. Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol 2004; 10(6): 910-912
- URL: https://www.wjgnet.com/1007-9327/full/v10/i6/910.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i6.910